LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.89 | 771.67 | 4003 | 5541 | 0.7224 | 0.7839 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.11 | 771.67 | 4333 | 5941 | 0.7293 | 0.7967 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.11 | 771.67 | 4301 | 5941 | 0.7239 | 0.7922 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 49.33 | 771.67 | 4729 | 6392 | 0.7398 | 0.8118 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 49.33 | 771.67 | 4536 | 6392 | 0.7096 | 0.7872 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 51.55 | 771.67 | 4914 | 6829 | 0.7195 | 0.8013 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 51.55 | 771.67 | 4915 | 6829 | 0.7197 | 0.8014 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 53.77 | 771.67 | 5261 | 7256 | 0.7250 | 0.8107 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 53.77 | 771.67 | 5037 | 7256 | 0.6942 | 0.7865 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 55.99 | 771.67 | 5533 | 7690 | 0.7195 | 0.8110 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 55.99 | 771.67 | 5306 | 7690 | 0.6900 | 0.7883 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.21 | 771.67 | 5853 | 8085 | 0.7239 | 0.8181 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 58.21 | 771.67 | 5426 | 8085 | 0.6711 | 0.7780 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.44 | 771.67 | 6173 | 8530 | 0.7236 | 0.8218 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 60.44 | 771.67 | 5596 | 8530 | 0.6560 | 0.7710 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.66 | 771.67 | 6484 | 8978 | 0.7222 | 0.8243 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.66 | 771.67 | 5723 | 8978 | 0.6374 | 0.7611 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.88 | 771.67 | 6703 | 9447 | 0.7095 | 0.8188 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.88 | 771.67 | 5859 | 9447 | 0.6202 | 0.7523 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.10 | 771.67 | 6989 | 9800 | 0.7132 | 0.8239 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.10 | 771.67 | 6032 | 9800 | 0.6155 | 0.7521 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.32 | 771.67 | 7392 | 10212 | 0.7239 | 0.8339 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.32 | 771.67 | 6108 | 10212 | 0.5981 | 0.7423 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 71.54 | 771.67 | 7592 | 10532 | 0.7208 | 0.8337 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 71.54 | 771.67 | 6104 | 10532 | 0.5795 | 0.7306 | MN20160304_L01 | E11 |